Building the Future of Psilocybin Policy in New Mexico
We’re proud to share that the Psychedelic Bar Association’s New Mexico Working Group recently submitted an official public comment to the New Mexico Department of
The Executive Order on Psychedelics has Significant Potential to Expand Access to Healing; Federal Agencies Should Promptly Develop Clear and Culturally-Informed Frameworks
[DENVER, COLORADO] — In response to President Trump’s April 18, 2026 executive order (EO) on “Accelerating Medical Treatments for Serious Mental Illness,” the Psychedelic Bar
PBA Statement on the Current Affairs of the Administration Targeting the Rule of Law and Integrity of the Law Profession
In response to executive orders targeting law firms and other challenges to the rule of law and due process, as well as statements by the
Psychedelic Patents: Ethical Lapses
High-Threat Patents: The Consequences of Inadequate Prior Art Research When Attorneys Fail to Acknowledge Traditional Psychedelic Uses Written by D. Burgundy Morgan, J.D. with contributions
Hiding in Plain Sight: Bias in Legal Contracts
A Call to Reform Contract Language Using the Term “Master” Written by D. Burgundy Morgan, J.D., Special Acknowledgment to Roman Haferd, J.D., Ethics Committee Board
A Reflection on FDA’s Rejection of MDMA-Assisted Therapy to Treat PTSD
The FDA’s rejection of Lykos’ NDA reveals a deeper communal quandary, especially in light of the agency’s inability to assess a human-based intervention combined with
Demystifying Decrim: What’s the difference between legalization, decriminalization, and deprioritization?
By: The Legalization and Regulation Committee of the Psychedelic Bar Association Are you inspired to help your state or city take big steps forward to
The What, Who, Why, and How of the Psychedelic Bar Association
What is the Psychedelic Bar Association? A Psychedelic Bar Association has been a long time coming. The organization was dreamed of in various forms as
Social Impact Primer 2023
The Social Impact Primer is a publication of the Corporate Forms and Business Practices Committee for use by PBA Founding Members, their clients, colleagues, and anyone interested in learning more about ethical business practices and social impact corporate forms, and their importance in the commercialization of psychedelics and plant medicines.